CANUEVO IS RUN BY ENTREPRENEURS & SCIENTISTS

Canuevo was started by Nils Rehmann, PhD and Daniel Carbo, MEng. Together the team has a combined experience in drug development of over 15 years and has been working in the cannabis industry around the world.
Canuevo adds value to cannabis by turning the plant and its components into products that have beneficial health effects to provide people with alternatives to treatments of diseases and pain maintaining the highest standards throughout development and production, such as GMP, ISO and ICH.

Canuevo has developed a proprietary drug delivery technology based on nano-encapsulation that enables better delivery of active ingredients to the skin cells and slowly release the compounds to maximize efficacy. We further plan to prove the efficacy of this delivery technology in our topical applications and are planning clinical studies with University partners to enter clinical trials and obtain pharmaceutical status for our formulations.

Nils Rehmann

Nils Rehmann

CEO

PhD in Pharmacology and Toxicology

Daniel Carbo

Daniel Carbo

CSO

Nanosystems Engineer